OBJECTIVE—To compare the ability of generic comorbidity and risk adjustment measures, a diabetes-specific measure, and a self-reported functional status measure to explain variation in health care expenditures for individuals with diabetes

Fihn, Stephan D.

Liu, Chuan-Fen

Maciejewski, Matthew L.

English

PubMed

OBJECTIVE—To compare the ability of generic comorbidity and risk adjustment measures, a diabetes-specific measure, and a self-reported functional status measure to explain variation in health care expenditures for individuals with diabetes.RESEARCH DESIGN AND METHODS—This study included a retrospective cohort of 3,092 diabetic veterans participating in a multisite trial. Two comorbidity measures, four risk adjusters, a functional status measure, a diabetes complication count, and baseline expenditures were constructed from administrative and survey data. Outpatient, inpatient, and total expenditure models were estimated using ordinary least squares regression. Adjusted R2 statistics and predictive ratios were compared across measures to assess overall explanatory power and explanatory power of low- and high-cost subgroups.RESULTS—Administrative data–based risk adjusters performed better than the comorbidity, functional status, and diabetes-specific measures in all expenditure models. The diagnostic cost groups (DCGs) measure had the greatest predictive power overall and for the low- and high-cost subgroups, while the diabetes-specific measure had the lowest predictive power. A model with DCGs and the diabetes-specific measure modestly improved predictive power.CONCLUSIONS—Existing generic measures can be useful for diabetes-specific research and policy applications, but more predictive diabetes-specific measures are needed

Maciejewski, M. L.

Liu, C.-F.

Fihn, S. D.

Carolina Digital Repository

Performance of Comorbidity, Risk Adjustment, and Functional Status Measures in Expenditure Prediction for Patients With Diabetes

BachmanDJ:Usingrisk-adjustmentmodels to identify high-cost risks. Med Care 41:1301–1312,

CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Development and validation of a diabetes mellitus severity index: a risk-adjustment tool for predicting health care resource use and costs. Pharmacother 25:676–684,

DeyoRA,CherkinDC,CiolMA:Adaptinga clinicalcomorbidityindexforusewithICD9-CMadministrativedatabases.JClinEpidemiol 45:613–619,

DiagnosticriskadjustmentforMedicaid:the disabilitypaymentsystem.HealthCareFinanc Rev 17:7–33,

Erickson P: Health Status and HealthPolicy:AllocatingResourcestoHealth Care.

Fihn SD: Comparison of risk adjustment measures based on self-report, administrative data and pharmacy records to predict mortality. Health Serv Outcomes Res Meth 6:21–36,

Fihn SD: The performance of administrative and selfreported measures for risk adjustment of Veterans Affairs expenditures. Health Serv Res 40:887–904,

Fihn SD: Validation of case-mix measures derived from self-reports of diagnoses and health.

Finding future high-cost cases: comparing prior cost versus diagnosis-based methods. Health Serv Res 36:194–206,

Grifﬁth JL: Proﬁling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results.

KatoneWJ:Diabetescomplicationsseverity index and risk of mortality, hospitalization, and healthcare utilization.

LA: Comparing self-reported health status and diagnosis-based risk adjustment to predict 1- and 2 to 5-year mortality. Health Serv Res 42:629– 643,

LM: Development and application of a population-oriented measure of ambulatory care case-mix.

O’Keeffe Rosetti MC: Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 41:84–99,

Proﬁling quality of diabetes care in a Veterans Affairs Healthcare System.

Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 25:119– 141,

Risk-adjusted quality of care rating for diabetes: ready for prime time? Diabetes Care 23:884–886,

RJ: Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilizationdata.JGenInternMed19:444– 450,

S: Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosisbased approaches.

Sauvigne A: Effects of sustained audit/feedback on self-reported health status of primary care patients.

SH: Development and testing of a new measure of case mix for use in ofﬁce practice. Med Care 33:AS47–55,

Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?

WareJEJr,SherbourneCD:TheMOS36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483,

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2606834

Performance of Comorbidity, Risk Adjustment, and Functional Status Measures in Expenditure Prediction for Patients With Diabetes

Abstract

Similar works

Full text

Available Versions

Carolina Digital Repository